Rubinstein-Taybi syndrome due to 16p13.3 microdeletion is a rare genetic condition that usually begins before birth and lasts throughout life. Early signs of Rubinstein-Taybi syndrome due to 16p13.3 microdeletion often include slower development, learning difficulties, short stature, and distinctive facial features, and some children also have broad thumbs or big toes. Many living with Rubinstein-Taybi syndrome due to 16p13.3 microdeletion need extra support with speech, feeding, behavior, or school, and some have heart, eye, or kidney problems that doctors monitor. Not everyone will have the same experience. Treatment focuses on regular checkups and supportive care such as developmental therapies, special education, and treatment for specific medical issues, and life expectancy can vary depending on the severity of associated health problems.

How many people live with Rubinstein-taybi syndrome due to 16p13.3 microdeletion?

Rubinstein-Taybi syndrome overall is estimated to affect about 65,000 to 81,000 people worldwide, based on a widely cited frequency of 1 in 100,000 to 125,000 people and current world population figures (MedlinePlus Genetics, 2024; UN World Population Prospects, 2024); because about 10% to 15% of cases are thought to be caused by a small missing piece of chromosome 16 called a 16p13.3 microdeletion, this subtype likely represents roughly 6,500 to 12,000 people worldwide, but that is an estimate rather than a direct count (GeneReviews, 2019). In the United States, Rubinstein-Taybi syndrome overall is estimated to affect about 2,700 to 3,400 people (MedlinePlus Genetics, 2024; U.S. Census Bureau, 2024), so this 16p13.3 microdeletion subtype likely accounts for about 270 to 500 people, again as an estimate rather than a direct count (GeneReviews, 2019).

Overview

Rubinstein-taybi syndrome due to 16p13.3 microdeletion

Symptoms

People with Rubinstein-Taybi syndrome due to 16p13.3 microdeletion often have broad thumbs and big toes, shorter height, and developmental delay. Many also have distinctive facial features, feeding problems in infancy, and learning difficulties.

Outlook and prognosis

Many living with Rubinstein-Taybi syndrome due to 16p13.3 microdeletion reach adulthood and can keep learning, but support needs often remain lifelong. Outlook varies with heart, breathing, feeding, and developmental challenges, so regular follow-up can make daily life steadier and safer.

Causes and risk factors

Rubinstein-Taybi syndrome due to 16p13.3 microdeletion is caused by a missing piece of chromosome 16, usually as a new genetic change before birth. It is rarely inherited. Lifestyle or environmental factors do not cause it, but they can affect health needs and complications.

Genetic influences

Genetics are central to Rubinstein-Taybi syndrome due to 16p13.3 microdeletion, because it is caused by a missing piece of chromosome 16. The size of the deletion and which genes are affected can influence features and severity.

Diagnosis

Rubinstein-Taybi syndrome due to 16p13.3 microdeletion is often suspected from clinical features seen at an exam. The genetic diagnosis of Rubinstein-Taybi syndrome is confirmed with genetic tests that detect the 16p13.3 deletion. Imaging may help check related findings.

Treatment and drugs

Care for Rubinstein-Taybi syndrome due to 16p13.3 microdeletion focuses on each person’s needs. Treatment often includes speech, physical, and occupational therapy, plus support for feeding, learning, behavior, and heart or breathing problems. Medicines treat symptoms such as seizures or reflux.

Symptoms

Rubinstein-Taybi syndrome due to 16p13.3 microdeletion can affect appearance, growth, learning, and several body systems from early life. Features can vary from person to person and may change over time. Some children are first noticed because of broad thumbs and big toes, slower development, or feeding trouble, while others come to attention after heart, kidney, or eye differences are found. The early features of Rubinstein-Taybi syndrome due to 16p13.3 microdeletion can overlap with other genetic conditions, so diagnosis often depends on a full exam and genetic testing.

Broad digits

Broad or angled thumbs and wide big toes are classic features of Rubinstein-Taybi syndrome due to 16p13.3 microdeletion. In daily life, this can affect grip, fine motor tasks like buttons or pencils, and sometimes shoe fit.

Facial features

Many living with this condition have a recognizable facial appearance, such as arched eyebrows, long eyelashes, a prominent nose, and a small upper jaw. These traits do not usually cause pain, but they can help doctors recognize the syndrome.

Growth and feeding

Some babies have trouble latching, reflux, or slow weight gain, and many remain shorter than average as they grow. What once felt effortless can start to require more energy or focus, especially around feeding in infancy and early childhood.

Developmental delay

Sitting, walking, and other milestones often happen later than expected. Learning differences are common, and many people with Rubinstein-Taybi syndrome due to 16p13.3 microdeletion need extra support at school and with daily skills.

How people usually first notice Rubinstein-taybi syndrome due to 16p13.3 microdeletion?

Rubinstein-Taybi syndrome due to a 16p13.3 microdeletion is usually first noticed in infancy or early childhood, when doctors or families see a pattern rather than just one sign: broad thumbs and big toes, slower growth, feeding difficulties, and delays in sitting, walking, or talking. Some babies are recognized even earlier because of noticeable physical features at birth, and a few are first suspected during pregnancy if an ultrasound shows differences in growth or development, although this is less common. In many families, the first signs of Rubinstein-Taybi syndrome are developmental delays combined with distinctive facial features or hand and foot differences, which then lead to genetic testing.

Dr. Wallerstorfer Dr. Wallerstorfer

Types of Rubinstein-taybi syndrome due to 16p13.3 microdeletion

No distinct types of Rubinstein-Taybi syndrome due to 16p13.3 microdeletion are widely recognized.

Can I slow down the onset of symptoms?

No, not in a proven way: because Rubinstein-Taybi syndrome due to a missing piece of chromosome 16 affects development before birth, there is no good evidence that diet, exercise, sleep, or other lifestyle changes can meaningfully delay when symptoms start. What does help is early, regular medical and developmental care to find and treat issues such as hearing, vision, feeding, sleep, heart, and learning problems as soon as they appear, but that manages symptoms rather than preventing the condition. Research is ongoing, and while it is understandable to want more control, early support can still make a real difference in day-to-day life.

What genetics can tell you about symptoms

In Rubinstein-Taybi syndrome caused by a 16p13.3 microdeletion, genetics can offer some clues about symptoms, but it usually cannot predict the exact day-to-day picture for one person. Because this type of change removes a small piece of chromosome 16 that may include the CREBBP gene and sometimes nearby genes as well, many living with larger deletions can have a broader mix of symptoms, more marked learning or developmental challenges, and sometimes earlier or more noticeable medical issues than people with other genetic causes of Rubinstein-Taybi syndrome. Even so, symptoms vary widely, so the same genetic finding does not always mean the same severity or timing.

Dr. Wallerstorfer Dr. Wallerstorfer

Causes and risk factors

For families, one of the biggest questions is what causes Rubinstein-Taybi syndrome due to 16p13.3 microdeletion. It is caused by a missing piece of chromosome 16 at 16p13.3, often involving the CREBBP gene, and this change is usually new in the child. Sometimes the deletion is inherited, so a parent with the same change has a much higher chance of passing it on. Diet, exercise, stress, and common pregnancy exposures are not known to cause this deletion, but overall health and early support can shape how much Rubinstein-Taybi syndrome affects daily life. Genetic testing can sometimes clarify your family risk.

What are the most common causes or risk factors?

This form of Rubinstein-Taybi syndrome is caused by a small missing piece of chromosome 16, usually including an important gene called CREBBP that helps control growth and development. Most cases happen by chance when the egg or sperm is formed or very early after conception, so there is usually no family history and nothing a parent did caused it, but in rare cases it can be passed down from a parent who also has the condition. There are no well-established lifestyle, diet, or environmental risk factors.

Environmental and biological risk factors

When families ask about risk factors for Rubinstein-Taybi syndrome due to 16p13.3 microdeletion, the main answer is that most cases happen by chance before birth. Most of the time, a small piece of chromosome 16 is lost during the making of an egg or sperm cell, or very soon after conception. Awareness of both biological and environmental influences helps you feel prepared, but for this specific syndrome, proven environmental triggers have not been identified.

New deletion

The biggest biological risk factor is a new chromosome change that happens by chance before birth. This is the most common reason for Rubinstein-Taybi syndrome due to 16p13.3 microdeletion and is usually not caused by anything a parent did.

Silent rearrangement

In a small number of families, one parent carries a balanced chromosome rearrangement without health problems of their own. This can make it more likely that a pregnancy will have the missing piece at 16p13.3.

Rare mosaicism

Rarely, some egg or sperm cells in a parent carry the chromosome change even when standard blood testing looks normal. This can raise the chance of the same deletion happening again in another pregnancy.

Environmental factors

No specific outside exposure has been clearly proven to cause Rubinstein-Taybi syndrome due to 16p13.3 microdeletion. That means medicines, foods, stress, or common day-to-day exposures are not known causes based on current evidence.

Genetic risk factors

Many living with Rubinstein-Taybi syndrome due to 16p13.3 microdeletion are born with it because a tiny piece of chromosome 16 is missing from the start. That missing segment usually includes the CREBBP gene, which plays a key role in growth and development. Most cases happen as a new genetic change in the child, but some are inherited from a parent. Genetic testing can help confirm the cause and estimate the chance of it happening again in a family.

Gene illustration
  • 16p13.3 deletion: This form happens when a very small piece is missing from chromosome 16 at a spot called 16p13.3. That missing piece disrupts genes needed for typical growth, learning, and development.

  • CREBBP loss: The key gene in this region is usually CREBBP. Losing one working copy of CREBBP is what most often causes the main features of Rubinstein-Taybi syndrome.

  • Larger deletions: Some deletions remove CREBBP as well as nearby genes. When more genes are missing, the condition can be more complex and may affect health more broadly.

  • De novo change: Most cases are caused by a new genetic change that starts in the egg, sperm, or very early embryo. In these families, parents usually do not have the deletion in their own blood cells.

  • Inherited deletion: Less often, the deletion is inherited from a parent who also carries it. If a parent has the same deletion, each pregnancy has a 1 in 2, or 50%, chance of passing it on. This is when the chance of having another child with Rubinstein-Taybi syndrome due to 16p13.3 microdeletion is highest.

  • Parental mosaicism: Rarely, a parent has the deletion in only some egg or sperm cells, even if their blood test is normal. This can slightly raise the chance of the condition happening again in another pregnancy, although the overall risk usually remains low.

Dr. Wallerstorfer Dr. Wallerstorfer

Lifestyle risk factors

Rubinstein-Taybi syndrome due to 16p13.3 microdeletion is a genetic condition, so lifestyle habits do not cause it. However, how lifestyle affects Rubinstein-Taybi syndrome can be important because daily routines may influence feeding, growth, constipation, sleep, behavior, mobility, and the risk of complications. The most relevant lifestyle risk factors for Rubinstein-Taybi syndrome are the habits that can worsen common medical or developmental challenges if they are not managed well.

Diet quality

Poor intake, limited food variety, or eating patterns that do not match chewing and swallowing abilities can worsen feeding difficulties and poor growth. In some people, low fiber and low fluid intake also make constipation and abdominal discomfort more likely.

Physical activity

Too little movement can worsen low muscle tone, reduced fitness, weight gain, and constipation, which are common concerns in Rubinstein-Taybi syndrome. Regular, adapted activity may support strength, balance, mobility, and daily functioning.

Sleep routine

Irregular sleep schedules, insufficient sleep, or bedtime habits that disrupt rest can aggravate daytime behavior problems, inattention, and fatigue. Good sleep routines may also help families notice when snoring or poor sleep quality suggests a treatable sleep disorder.

Oral habits

Inconsistent toothbrushing, high-sugar snacks, or frequent sweet drinks can increase the risk of dental decay and gum problems, which may already be harder to manage because of craniofacial and dental differences. Oral pain can then worsen eating, sleep, and behavior.

Risk prevention

People living with Rubinstein-Taybi syndrome due to 16p13.3 microdeletion cannot usually prevent the condition itself, because it starts from a chromosome change present from conception. Prevention is mainly about lowering the risk of complications, spotting problems early, and supporting day-to-day health and development. Different people need different prevention strategies—there’s no single formula. Regular follow-up can help catch issues that may affect breathing, feeding, growth, learning, hearing, vision, and the heart.

Regular checkups

Ongoing visits with a pediatrician and the right specialists can help prevent complications of Rubinstein-Taybi syndrome due to 16p13.3 microdeletion from being missed. This often means tracking growth, development, sleep, breathing, blood pressure, and any new symptoms over time.

Heart monitoring

Some people with Rubinstein-Taybi syndrome have heart differences that need early treatment or follow-up. Heart exams, including imaging when advised, can lower the risk of avoidable problems during illness, exercise, or surgery.

Hearing and vision

Regular hearing and eye checks can catch problems that may quietly affect language, learning, balance, and safety. Early treatment with glasses, hearing support, or other care can make daily life easier.

Feeding and reflux

Early help for feeding trouble, constipation, or reflux can reduce pain, poor growth, and chest infections from aspiration. If you notice choking, frequent vomiting, or slow weight gain, prompt assessment matters.

Can you prevent Rubinstein-taybi syndrome due to 16p13.3 microdeletion?

No, Rubinstein-Taybi syndrome caused by a missing small piece of chromosome 16 usually cannot be prevented. In many families, this genetic change happens by chance very early in development, so it is not caused by anything a parent did or did not do during pregnancy. If this condition runs in your family, genetic counseling before pregnancy may help you understand the chances of it happening again and talk through testing or family-planning options.

Transmission

Rubinstein-Taybi syndrome due to 16p13.3 microdeletion is not infectious, so it cannot spread from one person to another through touch, coughing, sex, blood, food, or everyday contact. Instead, the genetic transmission of Rubinstein-Taybi syndrome due to 16p13.3 microdeletion involves a small missing piece of chromosome 16.

In many living with Rubinstein-Taybi syndrome, this chromosome change happened for the first time in that child and was not inherited from either parent. Less often, a parent carries the same change and can pass it on, and when that happens, each pregnancy has a 1 in 2, or 50%, chance of inheriting it.

Gene illustration

When to test your genes

Genetic testing is most useful when a child has features suggestive of Rubinstein-Taybi syndrome, such as broad thumbs or big toes, growth or developmental differences, or characteristic facial features. Confirming a 16p13.3 microdeletion can guide screening for heart, kidney, vision, hearing, and developmental needs, and it can clarify recurrence risk for your family.

Dr. Wallerstorfer Dr. Wallerstorfer

Diagnosis

Many living with Rubinstein-Taybi syndrome due to 16p13.3 microdeletion are first evaluated because of a pattern of growth, learning, and physical features that seem to fit together rather than one isolated issue. Diagnosis is often based on these recognizable features and then confirmed with genetic testing. Getting a diagnosis is often a turning point toward answers and support.

Clinical features

Doctors look at the overall pattern of findings, such as broad thumbs or big toes, distinctive facial features, short stature, and developmental delay. In Rubinstein-Taybi syndrome due to 16p13.3 microdeletion, this exam helps show whether the features match the condition closely enough to guide testing.

Health history

A detailed family and health history can help place symptoms in context, including pregnancy history, growth, feeding, and early development. Doctors also ask about learning, behavior, and any heart, eye, hearing, or kidney concerns that can occur with this syndrome.

Genetic testing

The genetic diagnosis of Rubinstein-Taybi syndrome due to 16p13.3 microdeletion is usually confirmed with testing that looks for a missing piece of chromosome 16. This may be found by chromosomal microarray or similar genetic tests that detect small deletions too small to see on routine chromosome studies.

Gene analysis

If the diagnosis is still uncertain, your provider may suggest additional genetic tests to look closer at genes in the same region, especially CREBBP. This can help distinguish a 16p13.3 microdeletion from other genetic changes that can cause similar features.

How is Rubinstein-taybi syndrome due to 16p13.3 microdeletion diagnosed?

Doctors usually diagnose Rubinstein-Taybi syndrome by looking at a child’s growth, development, and body features, such as broad thumbs or big toes and a pattern of facial features that often goes with the condition, while also reviewing the medical history. The diagnosis is then confirmed with genetic testing, usually a blood test that looks for a tiny missing piece of chromosome 16 in the 16p13.3 area. Other checks, such as heart, eye, or hearing exams, may also be done to look for related health problems, but they do not confirm the condition by themselves.

Stages of Rubinstein-taybi syndrome due to 16p13.3 microdeletion

Rubinstein-Taybi syndrome due to 16p13.3 microdeletion does not have defined progression stages. This is because it is a genetic condition that is usually present from early life, and the pattern is more about a person’s individual features and support needs than a step-by-step worsening over time. Doctors usually start with a conversation about development, learning, growth, and any health concerns, along with a physical exam and review of family history. Diagnosis is usually confirmed with genetic testing, and follow-up focuses on monitoring issues such as development, behavior, hearing, vision, heart findings, and the early symptoms of Rubinstein-Taybi syndrome as they show up in daily life.

Outlook and prognosis

The outlook for Rubinstein-Taybi syndrome due to 16p13.3 microdeletion is variable, but many affected children survive into adulthood and can have a stable long-term course with appropriate medical, developmental, and educational support. Developmental delay and intellectual disability are usually lifelong, and people with larger 16p13.3 deletions may have more severe learning, growth, and medical problems than those with other causes of Rubinstein-Taybi syndrome. Early prognosis is influenced most by associated complications such as feeding difficulties, recurrent respiratory problems, airway issues, congenital heart defects, and severe infections, which can increase illness burden and occasionally be life-threatening in infancy or childhood. Seizures, kidney anomalies, vision or hearing problems, and orthopedic issues can also affect quality of life but are often manageable with ongoing specialist care. Published mortality data are limited, and there is no single predictable life expectancy, but in individuals without major organ complications, survival can extend well into adult life.

Long-term effects

For many families, the long-term picture with Rubinstein-Taybi syndrome due to 16p13.3 microdeletion centers on development, learning, and a wider range of health needs that can continue into adult life. Long-term effects vary widely, and some people have milder day-to-day challenges while others need ongoing medical and developmental support. In people with Rubinstein-Taybi syndrome, features can involve growth, behavior, sleep, feeding, and several body systems rather than only one area. Because a 16p13.3 microdeletion can remove nearby genetic material as well, some may have broader or more pronounced effects than others with Rubinstein-Taybi syndrome.

Learning and development

Developmental delay and intellectual disability often continue through childhood and adulthood. Many living with Rubinstein-Taybi syndrome need long-term support with speech, school skills, daily activities, and independent living.

Behavior and emotions

Attention problems, anxiety, autistic traits, and challenging behaviors can affect school, routines, and relationships over time. The early symptoms of Rubinstein-Taybi syndrome may become easier to recognize with age, but emotional and behavioral needs often remain an important part of long-term care.

Growth and feeding

Some children have slow growth, feeding difficulty, or poor weight gain early on, while others later develop excess weight. These long-term effects can shape strength, stamina, and general health across different life stages.

Sleep and breathing

Sleep problems are common and may include restless sleep or obstructive sleep apnea, where breathing briefly narrows or stops during sleep. Over time, poor sleep can add to daytime tiredness, attention difficulties, and behavior strain.

How is it to live with Rubinstein-taybi syndrome due to 16p13.3 microdeletion?

Living with Rubinstein-Taybi syndrome due to a 16p13.3 microdeletion often means daily life moves at a different pace, with many people needing extra support for learning, communication, coordination, and routine self-care, while also managing medical issues such as feeding difficulties, constipation, sleep problems, or repeated specialist visits. The experience can vary widely, but for many living with this condition, school, therapy, and structured routines become a regular part of life, and strengths such as warmth, sociability, and strong family bonds are often just as real as the challenges. For parents, siblings, teachers, and other caregivers, this can mean more hands-on help, advocacy, and long-term planning, yet it can also bring a deep sense of connection as everyone learns how to support the person’s independence, comfort, and participation in everyday life.

Treatment and drugs

Rubinstein-Taybi syndrome due to 16p13.3 microdeletion is usually treated by focusing on each person’s specific needs, since there is no single medicine that fixes the underlying genetic change. Care often includes regular follow-up with a pediatrician or other specialists, along with therapies that support day-to-day skills such as movement, speech, learning, feeding, and behavior. Doctors may also treat related health problems, which can include seizures, constipation, sleep trouble, reflux, hearing or vision problems, and heart issues if they are present. Treatment plans often combine several approaches. Support from family or friends can make daily treatment easier, especially when appointments, therapy exercises, and school supports become part of the routine.

Can you cure Rubinstein-taybi syndrome due to 16p13.3 microdeletion?

No, there is currently no cure for Rubinstein-Taybi syndrome caused by a missing small piece of genetic material on chromosome 16. Treatment cannot replace that missing piece, but it can help manage symptoms and support development, learning, and day-to-day health needs, including care for feeding, heart, breathing, vision, hearing, or behavior concerns if they happen. Regular checkups and early support can make a real difference for many people living with this condition.

Non-drug treatment

Day-to-day care for Rubinstein-Taybi syndrome due to 16p13.3 microdeletion often centers on helping with learning, communication, movement, feeding, and behavior rather than on a single treatment. Many living with Rubinstein-Taybi syndrome benefit from a team approach, because needs can change from infancy through adulthood. Supportive therapies can improve comfort, participation at school, and everyday independence. Not every approach works the same way, so care is usually tailored to the person’s strengths and challenges.

Early intervention

Therapy often starts early to support movement, play, communication, and learning during the first years of life. For many, this can mean regular sessions at home or in community programs before school age.

Physical therapy

Physical therapy can help with low muscle tone, balance, coordination, and delayed motor milestones. It may also support posture and safe movement if joints are loose or walking is tiring.

Occupational therapy

Occupational therapy focuses on daily skills such as dressing, feeding, handwriting, and using the hands well. Some may find adaptive tools, seating changes, or sensory strategies make school and home tasks easier.

Speech therapy

Speech and language therapy can help with delayed speech, understanding language, and social communication. If talking is limited, therapists may use communication boards or speech-generating devices so people with Rubinstein-Taybi syndrome can express needs more easily.

Your genes may have an impact on how drugs work for you

For people with Rubinstein-Taybi syndrome caused by a small missing piece of chromosome 16, there is no well-established proof that this diagnosis by itself changes how most everyday medicines work in a predictable way. Still, many living with this condition can have other health issues, such as seizures, reflux, breathing problems, or heart concerns, and that can affect which medicines are safest and how carefully doctors start and adjust them. In day-to-day care, this usually means closer watching for side effects, especially with medicines that can cause sleepiness or affect breathing, rather than using special gene-based drug testing as a routine part of treatment.

Dr. Wallerstorfer Dr. Wallerstorfer

Pharmacological treatments

People with Rubinstein-Taybi syndrome due to 16p13.3 microdeletion usually do not have one medicine that treats the condition itself. Medicines are used to help with specific problems such as seizures, attention difficulties, reflux, constipation, sleep trouble, or anxiety, and the right plan depends on the symptoms a person has. Not everyone responds to the same medication in the same way. Finding the right medication can be a process of trial, patience, and adjustment.

Seizure medicines

If seizures happen, doctors usually treat them with standard anti-seizure medicines such as levetiracetam, valproate, lamotrigine, or oxcarbazepine. The choice depends on the seizure type, age, and side effect profile.

ADHD medicines

Some children and adults with Rubinstein-Taybi syndrome have attention problems or hyperactivity that may be treated with stimulants such as methylphenidate or amphetamine salts, or with nonstimulants such as atomoxetine or guanfacine. These medicines can help with focus and day-to-day functioning when symptoms are significant.

Reflux treatment

Acid-reducing medicines such as omeprazole, lansoprazole, or famotidine may be used when reflux causes feeding trouble, discomfort, or poor sleep. In some children, treating reflux also helps with irritability that can look like part of the early symptoms of Rubinstein-Taybi syndrome.

Constipation relief

Constipation is often treated with medicines such as polyethylene glycol, lactulose, or senna when diet and fluids are not enough. For many, this can mean less belly pain, easier toileting, and fewer appetite problems.

Genetic influences

For many living with Rubinstein-Taybi syndrome due to 16p13.3 microdeletion, the genetic cause is already known: a very small missing piece of chromosome 16 affects the CREBBP gene, and sometimes nearby genes too. This missing segment changes early development, which is why this specific form of Rubinstein-Taybi syndrome is considered a confirmed genetic condition. Most cases happen for the first time in a child and are not caused by anything a parent did before or during pregnancy. Less often, the deletion is inherited in an autosomal dominant pattern, which means a parent who carries it has a 50% chance in each pregnancy of passing it on. Understanding whether a condition is inherited can guide next steps, especially when families are thinking about future pregnancies or whether relatives may need testing. A genetics specialist can explain recurrence risk, and genetic testing for Rubinstein-Taybi syndrome due to 16p13.3 microdeletion can help show whether the deletion was new or passed down.

Is Rubinstein-taybi syndrome due to 16p13.3 microdeletion genetic?

Genetics are central to Rubinstein-Taybi syndrome due to 16p13.3 microdeletion, because it is caused by a missing piece of chromosome 16. The size of the deletion and which genes are affected can influence features and severity.

Having a genetic risk is not necessarily a diagnosis

Changes in genes, called genetic variants, are a normal part of human biology and are common in the general population. Most of these variants do not directly affect health and are simply part of natural human diversity. For many genes, having a variant associated with a condition suggests a possible link rather than a definite diagnosis, especially when several genes and environmental factors play a role. In some situations, though, a single well-understood variant in a specific gene can be enough to confirm a diagnosis.

Dr. Wallerstorfer Dr. Wallerstorfer

Pharmacogenetics—how genetics influence drug effects

Treatment often focuses on the problems that affect daily life most, such as feeding difficulties, constipation, seizures, sleep trouble, or attention and behavior symptoms. Genetics is only one factor, but in Rubinstein-Taybi syndrome due to 16p13.3 microdeletion the deleted segment on chromosome 16 can involve the CREBBP gene and sometimes nearby genes, which helps explain why one person may need very different medicines and follow-up than another. In practice, the genetic result usually guides treatment indirectly: it helps the care team look for related issues in the heart, kidneys, airway, and development, and those findings can affect which drugs are chosen and how closely they are monitored. There is no standard pharmacogenetic test that can reliably tell doctors the best medicine for Rubinstein-Taybi syndrome due to 16p13.3 microdeletion itself, so treatment is still tailored to each person’s symptoms and other health conditions. For many living with this condition, this can mean extra caution with sedatives or anesthesia, especially if there are breathing or airway differences, and careful dose adjustments if seizures or behavior concerns are being treated. Genetic testing for Rubinstein-Taybi syndrome due to 16p13.3 microdeletion is still very useful, because it can help families and clinicians plan safer, more individualized care even when it does not point to one specific drug.

There are 0 Drugs to treat Rubinstein-taybi syndrome due to 16p13.3 microdeletion
Currently no available information

Interactions with other conditions

For many living with Rubinstein-Taybi syndrome due to 16p13.3 microdeletion, health concerns do not happen one at a time, and that can make everyday care more complex. Doctors call it a comorbidity when two conditions occur together, and in this syndrome that may include heart defects present from birth, breathing problems such as sleep apnea, feeding or reflux problems, constipation, kidney or urinary tract differences, hearing loss, or eye conditions. These related issues can affect one another; for example, reflux may worsen feeding difficulties, and sleep apnea can add to daytime tiredness, behavior challenges, or learning difficulties. Some may also have seizures or repeated ear and airway infections, which can further affect development, sleep, and school life. Because early symptoms of Rubinstein-Taybi syndrome can overlap with common childhood problems, coordinated follow-up with specialists is often helpful. Care is usually most effective when doctors look at the whole picture rather than treating each issue separately.

How genes can cause diseases

Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.

Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.

What other conditions can cause similar symptoms to Rubinstein-taybi syndrome due to 16p13.3 microdeletion?

Other conditions with similar features include classic Rubinstein-Taybi syndrome caused by a change in one gene rather than a missing piece of chromosome, as well as Cornelia de Lange syndrome and Floating-Harbor syndrome. Doctors may also sometimes consider other rare chromosome conditions or fetal alcohol spectrum disorder, since these can also cause slow development, short height, and similar facial or hand differences.

History

Families and communities once noticed patterns of children growing and developing in their own distinct way, even long before medicine had a clear name for Rubinstein-Taybi syndrome due to 16p13.3 microdeletion. In everyday life, this could mean a baby who fed slowly, a child with delayed milestones, or a school-age child who learned best with extra support. Early doctors described the condition by its visible features and developmental differences, especially the broad thumbs and big toes that often drew attention during an exam.

As medical science evolved, doctors began to realize that these features tended to appear together as part of the same syndrome rather than as separate findings. The condition was first clearly outlined in the medical literature in the 1960s, when specialists gathered reports from children who shared a similar pattern of growth, learning, and physical traits. That helped families and clinicians move from scattered observations to a more consistent diagnosis.

Over time, the way the condition has been understood has changed, and that has made diagnosis more accurate. What was once recognized mainly by appearance later came to include a fuller picture of development, behavior, feeding, and medical needs. Many living with Rubinstein-Taybi syndrome due to 16p13.3 microdeletion may have a wide range of symptoms, so not every child matched the earliest descriptions exactly.

Later, chromosome testing allowed doctors to see that some people with Rubinstein-Taybi syndrome had a tiny missing piece of chromosome 16, called a microdeletion at 16p13.3. This was an important step because it linked the day-to-day features of the condition with an underlying biological cause, even though not everyone with Rubinstein-Taybi syndrome has the same genetic change. For families, that shift often meant more certainty after a long search for answers.

In recent decades, awareness has grown, and earlier recognition has improved care. Doctors now better understand the early symptoms of Rubinstein-Taybi syndrome, including delays in development, feeding challenges, and differences in growth or body features that may prompt further evaluation. Looking back at the history of Rubinstein-Taybi syndrome due to 16p13.3 microdeletion helps explain why some adults were diagnosed late, while many children today are identified sooner and can be connected earlier with therapies, medical follow-up, and family support.

DISCLAIMER: The materials present on Genopedia.com, such as text, images, graphics, among other items (“Content”), are shared purely for informational reasons. This content should not replace professional health advice, medical diagnoses, or treatment procedures. Whenever you have health concerns or questions, it’s always recommended to engage with your doctor or another appropriate healthcare provider. If you read something on the Genopedia.com site, do not neglect professional medical counsel or delay in obtaining it. In case you believe you’re dealing with a medical crisis, get in touch with your medical professional or call emergency without delay. Genopedia.com doesn’t advocate for any particular medical tests, healthcare providers, products, methods, beliefs, or other data that could be discussed on the site. Please also note that the content, originally written in English and in part created with the help of artificial intelligence, is provided without any warranty, and any reliance on information offered by Genopedia.com, its staff, contributors invited by Genopedia.com, or site users is entirely at your own risk.
Genopedia © 2026 all rights reserved